AtriCure (Nasdaq: ATRC) — an innovator in treatments for atrial fibrillation and left atrial appendage management — is enjoying a rise in its stock value today after releasing results that beat the Street. Mason, Ohio–based AtriCure’s stock was up 67 cents per share, or 3.7%, closing at $18.99. The company reported yesterday evening that it revenue for […]
AtriCure Inc.
ActriCure launches AtriClip Flex V
AtriCure (NSDQ:ATRC) said yesterday that it won 510(k) clearance from the FDA for its AtriClip Flex V left atrial appendage closure device, touting it as the first AtriClip device with a trigger release for deployment. “The AtriClip Flex V is an exciting new product that we are pleased to be releasing to our U.S. customers,” president […]
These 10 medtech companies care a lot about research
Among the world’s largest medtech companies, these 10 spent the largest portion of their budgets on research and development. So what have they produced? Every year, Medical Design & Outsourcing pulls financial regulatory filings and reaches out to major, companies in some cases to create a list of the 100 largest medical device companies in […]
AtriCure launches AtriClip Pro-V in the US
AtriCure (NSDQ:ATRC) said today it launched its AtriClip Pro-V left atrial appendate exclusion system in the US. The newly launched AtriClip Pro-V is designed to be placed through a minimally-invasive surgery and features an open-ended design and tip-first closure mechanism for easier navigation, the Mason, Ohio.-based company claims. “Development of the AtriClip Pro-V is another step […]
AtriCure gains on Q2 revenue beat, raised outlook
AtriCure (NSDQ:ATRC) shares gained today after the medical device company yesterday reported higher-than-expected sales and raised its outlook for the rest of the year. The Mason, Ohio-based cardiovascular device company posted losses of -$6.9 million, or -21¢ per share, on sales of $45.2 million for the three months ended June 30, paring its losses by -16.1% […]
Lumicell taps ex-Accuray COO Londy as CEO | Personnel Moves July 18, 2017
Lumicell said last week it tapped former Accuray (NSDQ:ARAY) chief operating officer Kelly Londy as its new chief exec, with founder W. Lee moving to take the role of prez & chief scientific officer. Prior to holding the COO position at Accuray, Londy has held leadership positions at GE Healthcare (NYSE:GE) and Royal Philips (NYSE:PHG), Lumicell said. “We are […]
AtriCure’s Q1 numbers top estimates
AtriCure (NSDQ:ATRC) beat the consensus forecast at both the top and bottom lines with its 1st-quarter results, sending share prices up 3% today. Losses for the Mason, Ohio-based medical device company rose4.7% to -$10.2 million, or -32¢ per share, on sales growth of 14.8% for the 3 months ended March 31. Analysts on Wall Street were looking […]
AtriCure gains on Q4
AtriCure (NSDQ:ATRC) shares are up today after the company beat the forecast with its 4th-quarter and full-year bottom line. The Mason, Ohio-based company pared its losses by -21.0% to -$8.6 million, or -27¢ per share, on sales of $41.2 million for the 3 months ended Dec. 31, for a top-line gain of 14.8% compared with Q4 […]
AtriCure warns on tip detachment risk with Cobra Fusion cardiac ablation device
AtriCure (NSDQ:ATRC) in September warned doctors of the risk that the tip of its Cobra Fusion cardiac ablation catheter could dislodge and separate from the device. The Cobra Fusion device is designed to deliver both bipolar and monopolar energy to the ablation site. The device also uses suction to gently pulls tissue out of the path of circulating blood […]
AtriCure shares dip despite Street-beating Q2
AtriCure (NSDQ:ATRC) released 2nd quarter earnings late yesterday that topped the street in losses per share, but still saw shares dip in trading today. The Mason, Ohio-based company reported losses of $8.2 million, or 26¢ per share, on sales of $39.7 million for the 3 months ended June 30. That amounts to a 67.8% increase in […]
AtriCure wins CE Mark for AtriClip Pro2 LAA occluder
AtriCure (NSDQ:ATRC) said today it won CE Mark approval in the European Union for the AtriClip Pro2 left atrial appendage exclusion system designed for minimally-invasive LAA occlusion procedures. The AtriClip Pro2 system is designed with an ambidextrous locking and trigger-style clip closing mechanism, the West Chester, Ohio-based company said, as well as handle-based active articulation levers […]